Precision Neuroscience Co-founder’s Michael Mager and Dr. Benjamin Rapoport were both recent guests on Wall Street Journal “Bold Names” and Pushkin "What's Your Problem?" podcasts. Listen to both below!

Wall Street Journal: www.wsj.com/podcasts/wsj...

Pushkin: omny.fm/shows/whats-...

We’re proud to share that Nature Biomedical Engineering has published our foundational scientific report, providing an overview of Precision Neuroscience's system design and capabilities, and our first-in-human data from 2023.

Read the full study below.

www.nature.com/articles/s41...

In a world where too many patients are told, “There’s nothing more we can do,” I’m proud to be part of a team working to change that answer. - Jayme Strauss, CCO at Precision Neuroscience.

Read the full Healthcare Brew interview with Jayme below.

www.healthcare-brew.com/stories/2025...

Precision Neuroscience Co-founder Dr. Benjamin Rapoport will be a featured panelist at the upcoming 2025 New York BCI Symposium.

He’ll join leading experts in the brain-computer interface field for the session “BCI Trials Today and Tomorrow: Industry Perspectives”. Full details here: nybci.com.

Can brain-computer interfaces (BCIs) one day record our dreams? How do they move a cursor with thought alone? What does it really take to implant a brain chip?

Watch the latest episode of Wired's Tech Support series on Youtube below to find out!

www.youtube.com/watch?app=de...

"A growing roster of BCI trials is one thing. The actual number of patients implanted is another. And on that front, Precision Neuroscience might have a key advantage over the competition." - Sy Mukherjee, Inc. Magazine. Read Sy's full
article in Inc. Magazine below!

www.inc.com/sy-mukherjee...

Heading to the Neurocritical Care Society conference next week? Visit booth 508 to see Precision's Layer 7 in person. Layer 7 is the world’s only minimally invasive, high-bandwidth BCI — designed to create a direct communication pathway between the electrical activity of the brain and a computer.

Check out the latest episode of the Big Technology Podcast: “Brain Computer Interface Frontier: Movement, Coma, Depression, AI Merge”, featuring Precision Neuroscience Co-founders, Dr. Benjamin Rapoport and Michael Mager.

www.youtube.com/watch?v=GzFS...

Precision Neuroscience will be at the 2025 Neurocritical Care Society conference this month in Montreal, September 18th - 21st. Join us at the Precision booth to learn about the Layer 7 Cortical Interface, the world’s only high-bandwidth and minimally invasive brain-computer interface (BCI).

Business Insider recently spoke with Precision Neuroscience about our mission to restore independence to millions of people living with severe paralysis, using an approach that’s safer and less invasive than traditional brain-computer interface (BCI) tech.

www.businessinsider.com/precision-ne...

We’re excited to share that Precision Neuroscience has been featured on Welcome to the Jungle's 2025 Building for Better Curated List — highlighting companies that are actively hiring and leading the way in purpose-driven business. We're hiring! See all our open roles: precisionneuro.io/careers

August is Neurosurgery Awareness Month — a time to celebrate the dedication of neurosurgeons at the very frontier of medicine. The 2025 theme, “We are Neurosurgery: Every Patient. One Purpose.", reminds us that every moment at a patient’s side is driven by one mission: giving people back hope.

Precision Neuroscience has announced a new clinical research project with Beth Israel Deaconess Medical Center (BIDMC). Read the full press release below!

Precision Neuroscience's CEO and Co-founder, Michael Mager, features in the second edition of Neurotech Insider, where he discusses how Precision has achieved the highest resolution picture of the awake human brain that's ever been seen. Read more below.

neurotechnology.substack.com/p/neurotech-...

Precision Neuroscience is hiring!

Learn more about the work Precision is doing here: precisionneuro.io

See our open positions here: lnkd.in/eyY_Wf-N

Great to see Precision Neuroscience make Linknovate's “Top 50 Startups to Watch” list for the second year in a row!

Thank you Linknovate for recognizing Precision in the HEALTH-TECH category for “pushing the boundaries of innovation”!

Since 2004, the American Heart Association's signature women's initiative, Go Red For Women, has addressed the clinical care gaps of one of women’s greatest health threats, cardiovascular disease (CVD). Stop by the Precision booth at ISC 2025 today to get your Go Red For Women logo on your latte!

Precision Neuroscience is coming ISC 2025! Visit booth 611 to experience the first brain-computer Interface (BCI) company to join the stroke community at the 2025 International Stroke Conference in Los Angeles next week. Stop by and meet the Precision team, and learn about the future of BCIs!

The North American Neuromodulation Society (NANS) 2025 meeting commences this week in Orlando. Precision Neuroscience CEO & Co-Founder, Michael Mager, will be a featured panelist during "BCI Technology Update" session, where the latest innovations, research, and use cases for BCIs will be discussed.

Precision Neuroscience is heading to the North American Neuromodulation Society (NANS) 2025 annual conference in Orlando!

Stop by booth 200 to learn more about the potential life changing benefits of brain-computer interfaces (BCI) for the millions of people living with neurological disorders.

Precision Neuroscience is heading to the J.P. Morgan Healthcare Conference in San Francisco next week!
To learn more about how Precision is connecting human intelligence & artificial intelligence, visit www.precisionneuro.io.

Connect with us at [email protected] to schedule a meeting!

Great article from Harvard Magazine discussing the first time the Precision Neuroscience brain-computer interface (BCI) was tested on a human being in April 2023 as part of a pilot clinical study with WVU Rockefeller Neuroscience. Read more on this, and the Precision Neuroscience origin story below.

Breaking News: Precision Neuroscience Raises $102M in Series C Funding. We're thrilled to announce the close of our Series C funding round, bringing our total funding to $155M. This investment is a testament to the growing momentum in our field and the impact it could have on lives around the world.

Very happy to announce that Precision Neuroscience has made Inc. Magazine's 2024 Best in Business Awards list in two categories: On the Rise & General Excellence!

Read the full news here: www.globenewswire.com/news-release...